Evidence map›Paper›PMID 27297994›Full record

Trial reportThe Journal of allergy and clinical immunology2016

Impact of peanut consumption in the LEAP Study: Feasibility, growth, and nutrition.

Mary Feeney, George Du Toit, Graham Roberts, Peter H Sayre, Kaitie Lawson, Henry T Bahnson, Michelle L Sever, Suzana Radulovic, Marshall Plaut, Gideon Lack and 1 more

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of allergy and clinical immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00329784 (Induction of Tolerance Through Early Introduction of Peanut in High-Risk Children), which is not on this map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00329784 phase2completednot on this map

Induction of Tolerance Through Early Introduction of Peanut in High-Risk Children (ITN032AD)

TypeinterventionalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2006 to 2014Enrolled640ConditionsEczema, Egg Allergy, Food AllergyArmsPeanut Consumption Group
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 81 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Trial
  4. Trial
  5. Evolution of epitope-specific IgE and IgGThe Journal of allergy and clinical immunology · 2021
    Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Observational
  12. Review
  13. Review
  14. Article
  15. A pragmatic approach to infant feeding for food allergy prevention.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2022
    Article
  16. The association between duration of breastfeeding and childhood asthma outcomes.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2022
    Article
  17. Review
  18. Dietary exposures and allergy prevention in high-risk infants.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2022
    Article
  19. Article
  20. Real-World LEAP Implementation.Current allergy and asthma reports · 2021
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Mary Feeney *Department of Pediatric Allergy, Division of Asthma, Allergy and Lung Biology, King's College London and Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
George Du Toit *Department of Pediatric Allergy, Division of Asthma, Allergy and Lung Biology, King's College London and Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
Graham RobertsUniversity of Southampton and NIHR Respiratory Biomedical Research Unit, Southampton and David Hide Centre, Isle of Wight, United Kingdom.
Peter H SayreImmune Tolerance Network and Division of Hematology-Oncology, Department of Medicine, University of California, San Francisco.
Kaitie LawsonRho Federal Systems Division, Chapel Hill, NC.
Henry T BahnsonRho Federal Systems Division, Chapel Hill, NC.
Michelle L SeverRho Federal Systems Division, Chapel Hill, NC.
Suzana RadulovicDepartment of Pediatric Allergy, Division of Asthma, Allergy and Lung Biology, King's College London and Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
Marshall PlautNational Institute of Allergy and Infectious Diseases, Bethesda, MD.
Gideon LackDepartment of Pediatric Allergy, Division of Asthma, Allergy and Lung Biology, King's College London and Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
Immune Tolerance Network LEAP Study Team
King's College London · GBRho (United States) · USDavid Hide Asthma and Allergy Research Centre · GBGuy's and St Thomas' NHS Foundation Trust · GBNational Institute of Allergy and Infectious Diseases · USUniversity of California, San Francisco · US

Funding

Immune Tolerance Network UM1 2023 SupplementUM1AI109565 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI Mark S Anderson, Jane Hoyt Buckner · 2014 to 2026
$451.6M
Transplantation GroupUM2AI117870 · NIAID · RHO FEDERAL SYSTEMS DIVISION, INC. · PI DAVID, GLORIA · 2015 to 2023
$208.1M
IMMUNE TOLERANCE NETWORK-266015416-266015416N01AI015416 · NIAID · REGENTS OF THE UNIVERSITY OF C · PI BLUESTONE, JEFFREY A · 2002 to 2006
–
NIAID NIH HHS HHSN272200800029CNIAID NIH HHS N01 AI015416NIAID NIH HHS UM1 AI109565NIAID NIH HHS UM2 AI117870
6 · The paper itself

Abstract

backgroundEarly introduction of peanut is an effective strategy to prevent peanut allergy in high-risk infants; however, feasibility and effects on growth and nutritional intake are unknown.

objectiveWe sought to evaluate the feasibility of introducing peanut in infancy and explore effects on growth and nutritional intake up to age 60 months.

methodsIn the Learning Early About Peanut Allergy trial, 640 atopic infants aged 4 to 11 months were randomly assigned to consume (6 g peanut protein per week) or avoid peanut until age 60 months. Peanut consumption and early feeding practices were assessed by questionnaire. Dietary intake was evaluated with prospective food diaries. Anthropometric measurements were taken at all study visits.

resultsPeanut was successfully introduced and consumed until 60 months, with median peanut protein intake of 7.5 g/wk (interquartile range, 6.0-9.0 g/wk) in the consumption group compared with 0 g in the avoidance group. Introduction of peanut in breast-feeding infants did not affect the duration of breast-feeding. There were no differences in anthropometric measurements or energy intakes between groups at any visits. Regular peanut consumption led to differences in dietary intakes. Consumers had higher intakes of fat and avoiders had higher carbohydrate intakes; differences were greatest at the upper quartiles of peanut consumption. Protein intakes remained consistent between groups.

conclusionsIntroduction of peanut proved feasible in infants at high risk of peanut allergy and did not affect the duration of breast-feeding nor impact negatively on growth or nutrition. Energy balance was achieved in both groups through variations in intakes from fat and carbohydrate while protein homeostasis was maintained.

Indexed as

ArachisDietNutritional Physiological PhenomenaSurveys and QuestionnairesAnthropometryBreast FeedingDiet RecordsFemaleGrowth and DevelopmentHumansInfantLongitudinal StudiesMaleNutrition AssessmentPeanut HypersensitivityProspective Studiesallergy preventionbreast-feedingFood allergygrowthinfant feedingnutritionpeanutprospective food diaryprotein homeostasis

Identifiers

PMID27297994
PMCPMC5056823
OpenAlexW2415044487

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.